ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
63 532,22
0,19%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Sana Biotechnology Inc (SANA)

  7. Sana Biotechnology Inc (SANA) Actualités

SANA Sana Biotechnology Inc

8,72
0,22 (2,59%)
27 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Sana Biotechnology Inc SANA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,22 2,59% 8,72 01:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
8,57 8,46 8,88 8,72 8,50
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
08/3/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:12EDGAR2Form 8-K - Current report
29/2/202422:05GLOBESana Biotechnology Reports Fourth Quarter and Full Year 2023..
28/2/202422:05GLOBESana Biotechnology to Present at the Cowen 44th Annual..
14/2/202422:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/2/202422:05GLOBESana Biotechnology Announces Publication of Preclinical..
12/2/202422:05GLOBESana Biotechnology Announces Closing of Upsized Public..
08/2/202423:20EDGAR2Form 8-K - Current report
08/2/202422:49EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/2/202407:22GLOBESana Biotechnology Announces Pricing of Upsized Public..
08/2/202403:59EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
07/2/202423:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/2/202422:12EDGAR2Form 8-K - Current report
07/2/202422:01GLOBESana Biotechnology Announces Proposed Public Offering of..
09/1/202415:00EDGAR2Form 8-K - Current report
05/1/202415:00GLOBESana Biotechnology Announces FDA Clearance of..
03/1/202422:05GLOBESana Biotechnology to Present at the 42nd Annual J.P. Morgan..
18/12/202322:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:34EDGAR2Form 144 - Report of proposed sale of securities
11/12/202322:01EDGAR2Form 8-K - Current report
11/12/202315:00GLOBESana Biotechnology Highlights Preclinical Data Supporting..
01/12/202322:05GLOBESana Biotechnology Publishes Early Clinical Data Showing..
28/11/202301:01PRNUSFlagship Pioneering Marks Official Opening of UK Hub with..
21/11/202315:00GLOBESana Biotechnology to Present at November and December 2023..
21/11/202312:00PRNUSFlagship Pioneering Unveils Quotient Therapeutics to Create..
17/11/202315:00GLOBEUppsala University Hospital and Sana Biotechnology Announce..
09/11/202322:05GLOBESana Biotechnology Announces FDA Clearance of..
08/11/202322:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:14EDGAR2Form 8-K - Current report
08/11/202322:05GLOBESana Biotechnology Reports Third Quarter 2023 Financial..
03/11/202321:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202321:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202314:05GLOBESana Biotechnology Announces Five Presentations at the 65th..
01/11/202315:30PRNUSFlagship Pioneering Launches Pioneering Intelligence
10/10/202322:21EDGAR2Form 8-K - Current report
10/10/202322:15GLOBESana Biotechnology Announces Increased Focus on..
13/9/202312:04EDGAR2Form 8-K - Current report
11/9/202312:30PRNUSFlagship Pioneering Announces Appointment of Amanda Kay as..
30/8/202322:05GLOBESana Biotechnology to Present at September 2023 Investor..
29/8/202315:00PRNUSInvaio achieves first registration for citrus greening..
21/8/202322:05EDGAR2Form 8-K - Current report
03/8/202322:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202322:14EDGAR2Form 8-K - Current report
03/8/202322:05GLOBESana Biotechnology Reports Second Quarter 2023 Financial..
16/6/202315:00GLOBESana Biotechnology Highlights Preclinical Data from..
31/5/202322:05GLOBESana Biotechnology to Present at June 2023 Investor..
16/5/202312:00PRNUSFlagship Pioneering Launches Metaphore Biotechnologies to..
08/5/202322:35GLOBESana Biotechnology Announces Preclinical Data Published in..
08/5/202322:05GLOBESana Biotechnology Reports First Quarter 2023 Financial..

Dernières Valeurs Consultées

NASDAQ
SANA
Sana Biotechnology
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés